Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Hossain, Sharif ^a   Yamamoto, Hirofumi ^b   Chowdhury, Ezharul Hoque ^c   Wu, Xin ^b   Hirose, Hajime ^b   Haque, Amranul ^d   Doki, Yuichiro ^b   Mori, Masaki ^b   Akaike, Toshihiro ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MONASH UNIVERSITY MALAYSIA   (Malaysia)

^d University of California Davis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; DOXORUBICIN CARBONATE APATITE COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CHEMOSENSITIVITY; COLON CANCER; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG UPTAKE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; APATITES; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOCOMPOSITES;

MUS MUSCULUS;

EID: 84876186593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060428     Document Type: Article

References (48)

1. Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, et al. (2005) Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci 102: 12962-12967.
2. Nishiyama N, Okazaki S, Cabral H, Miyamoto M, Kato Y, et al. (2003) Novel ciplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 63: 8977-8983.
3. Duncan R, (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2: 347-360.
4. Matsumura Y, Maeda H, (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumor tropic accumulation of proteins and antitumor agent SMANCS. Cancer Res 46: 6387-6392.
5. Farokhzad OC, Langer R, (2009) Impact of Nanotechnology on Drug Delivery. ACS Nano 27: 16-20.
6. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, et al. (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2: 751-760.
7. Ulbrich K, Subr V, (2004) Polymeric Anticancer Drugs with pH-Controlled Activation. Adv Drug Deliv Rev 56: 1023-1050.
8. Etrych T, Jelínková M, Ríhová B, Ulbrich K, (2001) New HPMA copolymers containing doxorubicin bound via pH-Sensitive linkage: Synthesis and preliminary in vitro and in vivo biological properties. J Control Release 73: 89-102.
9. Rijcken CJ, Soga O, Hennink WE, Van Nostrum CF, (2007) Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: An attractive tool for drug delivery. J Control Release 120: 131-148.
10. Gillies ER, Jonsson TB, Fréchet JM, (2004) Stimuli-Responsive Supramolecular Assemblies of Linear-Dendritic Copolymers. J Am Chem Soc 126: 11936-11943.
11. Maeda M, Kumano A, Tirrell DA, (1988) H-induced release of calcein of phosphatidylcholine vesicles bearing surface-bound polyelectrolyte chains. J Am Chem Soc 110: 7455-59.
12. Kim D, Lee ES, Park K, Kwon IC, Bae YH, (2008) Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. Pharm Res 25: 2074-2082.
13. Vail DM, Amantea MA, Colbern GT, Martin FJ, Hilger RA, et al. (2004) Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. Semin Oncol 31: 16-35.
14. Torchilin VP, (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 54: 145-160.
15. David A, Kopeckova P, Minko T, Rubinstein A, Kopecek J, (2004) Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Eur J Cancer 40: 148-57.
16. Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, et al. (2003) Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Controlled Release 91: 61-73.
17. Kwon GS, (1998) Diblock copolymer nanoparticles for drug delivery. Crit Rev Ther Drug Carrier Syst 15: 481-512.
18. Brannon-Peppas L, Blanchette JO, (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56: 1649-1659.
19. Panyam J, Labhasetwar V, (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55: 329-347.
20. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L, (2004) Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity, Pharmacol Rev. 56: 185-229.
21. Pollakis G, Goormaghtigh E, Ruysschaert JM, (1983) Role of the quinine structure in the mitochondrial damage induced by antitumor anthracyclines. FEBS Lett 55: 267-272.
22. Singal PK, Iliskovic N, (1998) Doxorubicin-induced cardiomyopathy. New Engl J Med 339: 900-905.
23. Singal PK, Iliskovic N, Li T, Kumar D, (1997) Adriamycin cardiomyopathy: Pathophysiology and prevention. FASEB J 11: 931-936.
24. Hossain S, Stanislaus A, Chua MJ, Tada S, Tagawa Y, et al. (2010) Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes. J Control Release 147: 101-108.
25. Hossain S, Tada S, Akaike T, Chowdhury EH, (2010) Influences of electrolytes and glucose on formulation of carbonate apatite nanocrystals for efficient gene delivery to mammalian cells. Anal Biochem 397: 156-161.
26. Hossain S, Chowdhury EH, Akaike T, (2011) Nanoparticles and toxicity in therapeutic delivery: The ongoing debate. Therapeutic Deliv 2: 125-132.
27. Tada S, Chowdhury EH, Cho CS, Akaike T, (2010) pH-sensitive carbonate apatite as an intracellular protein transporter. Biomaterials 31: 1453-1459.
28. Chowdhury EH, Maruyama A, Kano A, Nagaoka M, Kotaka M, et al. (2006) pH-sensing nano-crystals of carbonate apatite: Effects on intracellular delivery and release of DNA for efficient expression into mammalian cells. Gene 376: 87-94.
29. Kutsuzawa K, Akaike T, Chowdhury EH, (2008) The influence of the cell adhesive proteins E-cadherin and fibronectin embedded in carbonate-apatite DNA carrier on transgene delivery and expression in a mouse embryonic stem cell line. Biomaterials 29: 370-376.
30. Chowdhury EH, (2007) pH-sensitive nano-crystals of carbonate apatite for smart and cell-specific transgene delivery. Expert Opin Drug Deliv 4: 193-196.
31. Chowdhury EH, Akaike T, (2007) High performance DNA nano-carriers of carbonate apatite: multiple factors in regulation of particle synthesis and transfection efficiency. Int J Nanomedicine 2: 101-106.
32. Chowdhury EH, Akaike T, (2005) Bio-functional inorganic materials: An attractive branch of gene-based nano-medicine delivery for 21st century. Curr Gene Ther 5: 669-676.
33. Chowdhury EH, Akaike T, (2005) A bio-recognition device developed onto nano-crystals of carbonate apatite for cell-targeted gene delivery. Biotechnol Bioeng 90: 414-442.
34. Maeda H, (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41: 189-220.
35. Lee CH, Cheng SH, Huang IP, Souris JS, Yang CS, et al. (2010) Intracellular pH responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Ed Engl 49: 8214-8219.
36. Stuart MA, Huck WT, Genzer J, Müller M, Ober C, et al. (2010) Emerging applications of stimuli-responsive polymer materials. Nat Mater 9: 101-113.
37. Meng H, Xue M, Xia T, Zhao YL, Tamanoi F, et al. (2010) Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH sensitive nanovalves. J Am Chem Soc 132: 12690-12697.
38. Zhu Y, Shi J, Shen W, Dong X, Feng J, et al. (2005) Stimuli-Responsive Controlled Drug Release from a Hollow Mesoporous Silica Sphere/Polyelectrolyte Multilayer Core-Shell Structure. Angew Chem Int Ed Engl 44: 5083-5087.
39. Lee ES, Gao Z, Bae YH, (2008) Recent progress in tumor pH targeting nanotechnology. J Control Release 132: 164-170.
40. Kim D, Gao Z, Lee ES, Bae YH, (2009) In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol Pharm 6: 1353-1362.
41. Lee ES, Gao Z, Kim D, Park K, Kwon IC, et al. (2008) Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. J Control Release 129: 228-236.
42. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM, (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5: 219-234.
43. Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, et al. (2007) Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm 329: 94-102.
44. Mohajer G, Lee ES, Bae YH, (2007) Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells. Pharm Res 24: 1618-1627.
45. Lee ES, Na K, Bae YH, (2005) Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 103: 405-418.
46. Lee ES, Kim D, Youn YS, Oh KT, Bae YH, (2008) A novel virus-mimetic nanogel vehicle, Angew. Chem Int Ed 47: 2418-2421.
47. Aryal S, Hu CM, Zhang L, (2010) Polymer - Cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano 4: 251-258.
48. Ko J, Park K, Kim Y, Kim MS, Han JK, et al. (2007) Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(β-amino ester) block copolymer micelles for cancer therapy. J Control Release 123: 109-115.